Sanofi SA Total Liabilities

Latest as of December 2025: €55.10 Billion EUR ≈ $64.41 Billion USD

Sanofi SA total liabilities. Based on the latest financial reports, Sanofi SA (SAN) has total liabilities worth €55.10 Billion EUR (≈ $64.41 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SAN financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Sanofi SA (1999–2025)

Total liabilities of Sanofi SA from 1999 to 2025. This chart illustrates how Sanofi SA's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Sanofi SA's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Sanofi SA Competitors by Total Liabilities

The table below lists competitors of Sanofi SA ranked by their total liabilities.

Company Country Total Liabilities
Duke Energy Corporation
NYSE:DUK
USA $144.23 Billion
Amphenol Corporation
NYSE:APH
USA $22.73 Billion
ROLLS ROYCE H.ADR/ LS-20
F:RRU1
Germany €35.36 Billion
Compagnie Financière Richemont SA
JSE:CFR
South Africa ZAC19.19 Billion
Tata Consultancy Services Limited
NSE:TCS
India Rs735.22 Billion
U.S. Bancorp
NYSE:USB
USA $658.02 Billion
Fortinet Inc
NASDAQ:FTNT
USA $9.31 Billion
Mizuho Financial Group Inc
F:MZ8A
Germany €286.31 Trillion

Liability Composition Analysis (1999–2025)

This chart breaks down Sanofi SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SAN total asset value.

Liquidity & Leverage Metrics

Sanofi SA Total Liabilities Ratios Explained

Sanofi SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.09 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.27 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.77 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.43 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sanofi SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sanofi SA (1999–2025)

The table below shows the annual total liabilities of Sanofi SA from 1999 to 2025.

Year Total Liabilities Change
2025-12-31 €55.10 Billion
≈ $64.41 Billion
+0.28%
2024-12-31 €54.94 Billion
≈ $64.23 Billion
+5.43%
2023-12-31 €52.11 Billion
≈ $60.92 Billion
+1.05%
2022-12-31 €51.57 Billion
≈ $60.29 Billion
+0.70%
2021-12-31 €51.21 Billion
≈ $59.87 Billion
+0.10%
2020-12-31 €51.16 Billion
≈ $59.81 Billion
-4.60%
2019-12-31 €53.63 Billion
≈ $62.70 Billion
+2.40%
2018-12-31 €52.37 Billion
≈ $61.23 Billion
+25.98%
2017-12-31 €41.57 Billion
≈ $48.60 Billion
-11.45%
2016-12-31 €46.95 Billion
≈ $54.89 Billion
+6.43%
2015-12-31 €44.11 Billion
≈ $51.57 Billion
+7.26%
2014-12-31 €41.12 Billion
≈ $48.08 Billion
+5.39%
2013-12-31 €39.02 Billion
≈ $45.62 Billion
-9.13%
2012-12-31 €42.94 Billion
≈ $50.20 Billion
-3.05%
2011-12-31 €44.30 Billion
≈ $51.79 Billion
+38.53%
2010-12-31 €31.98 Billion
≈ $37.38 Billion
+1.18%
2009-12-31 €31.60 Billion
≈ $36.95 Billion
+17.41%
2008-12-31 €26.92 Billion
≈ $31.47 Billion
+10.84%
2007-12-31 €24.28 Billion
≈ $28.39 Billion
-14.65%
2006-12-31 €28.45 Billion
≈ $33.26 Billion
-29.97%
2005-12-31 €40.63 Billion
≈ $47.50 Billion
-7.42%
2004-12-31 €43.88 Billion
≈ $51.31 Billion
+1190.09%
2003-12-31 €3.40 Billion
≈ $3.98 Billion
-0.24%
2002-12-31 €3.41 Billion
≈ $3.99 Billion
-18.39%
2001-12-31 €4.18 Billion
≈ $4.88 Billion
+18.93%
2000-12-31 €3.51 Billion
≈ $4.11 Billion
+9.34%
1999-12-31 €3.21 Billion
≈ $3.76 Billion
--

About Sanofi SA

PA:SAN France Drug Manufacturers - General
Market Cap
$118.74 Billion
€101.56 Billion EUR
Market Cap Rank
#268 Global
#11 in France
Share Price
€84.10
Change (1 day)
+3.85%
52-Week Range
€69.99 - €90.44
All Time High
€109.62
About

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting aga… Read more